| CAS ID: | 171596-29-5 |
| Molecular Formula: | C22H19N3O4 |
| Molecular Weight: | 389.4 g/mol |
| Monoisotopic Mass: | 389.1376 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | TADALAFIL | CIALIS | IC-351 | ADCIRCA | IC351 |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3/t16-,21-/m1/s1 | See All |
| InChI Key: | WOXKDUGGOYFFRN-IIBYNOLFSA-N | |
| Smiles: | CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c5ccc6OCOc6c5)C1=O | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT02611336 | Disease | Cardiac fibrosis |
| Phase | Phase 2 | Status | Recruiting |
| First Received | November 20, 2015 | Last Verified | January 30, 2018 |
| Sponsor | Andrea M. Isidori | ||
Trial Record 2
| ClinicalTrial ID | NCT02611258 | Disease | Cardiac fibrosis |
| Phase | Phase 2 | Status | Recruiting |
| First Received | November 20, 2015 | Last Verified | January 30, 2018 |
| Sponsor | Andrea M. Isidori | ||